United States Biotechnology & Medical Research

Travere Therapeutics Inc (TVTX)

Track

Track

Travere Therapeutics witnessed significant insider trading activity recently, with executives and directors executing twenty-three sales totaling over 62 million dollars. These divestments occurred following the August results financiers, despite a fifteen percent stock price increase over ninety days. No purchase activity was recorded during this period, reflecting a trend of liquidation among key leadership personnel.
Ticker: TVTX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Travere Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.8
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
492.81
Quantity 10,076 -5.9%
Value US$460,836
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
450.14
Quantity 89,645 -49.6%
Value US$4,016,008
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
393.35
Quantity 26,817 -5.7%
Value US$3,370,571
2.7
ERIC DUBE Director; Officer Executive Director
Transaction date
Proposed sale
Price
63.48
Quantity 1,000
Value US$100,000
2.8
PETER HEERMA Officer Officer
Transaction date
Proposed sale
Price
63.48
Quantity 1,000
Value US$100,000
2.3
ROTE WILLIAM E. Chief Research Officer Officer
Transaction date
Planned sale
Price
63.61
Quantity 1,000 -32.7%
Value US$100,000
2.3
ROTE WILLIAM E. Chief Research Officer Officer
Transaction date
Planned sale
Price
63.12
Quantity 1,000 -30.8%
Value US$100,000
2.8
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
63.65
Quantity 1,000 -40.3%
Value US$100,000
2.8
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
63.25
Quantity 1,000 -32.3%
Value US$100,000
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
63.64
Quantity 1,000 -18.2%
Value US$100,000
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
63.26
Quantity 1,000 -15.9%
Value US$100,000
2.7
ERIC DUBE Director; Officer Executive Director
Transaction date
Proposed sale
Price
62.51
Quantity 1,000
Value US$100,000
2.3
WILLIAM ROTE Officer Officer
Transaction date
Proposed sale
Price
62.51
Quantity 1,000
Value US$100,000
2.8
PETER HEERMA Officer Officer
Transaction date
Proposed sale
Price
62.51
Quantity 1,000
Value US$100,000
2.3
ROTE WILLIAM E. Chief Research Officer Officer
Transaction date
Planned sale
Price
65.31
Quantity 1,000 -0.3%
Value US$100,000
2.3
ROTE WILLIAM E. Chief Research Officer Officer
Transaction date
Planned sale
Price
63.65
Quantity 1,000 -3.0%
Value US$100,000
2.3
ROTE WILLIAM E. Chief Research Officer Officer
Transaction date
Planned sale
Price
62.66
Quantity 1,000 -22.2%
Value US$100,000
2.3
ROTE WILLIAM E. Chief Research Officer Officer
Transaction date
Planned sale
Price
61.99
Quantity 1,000 -32.9%
Value US$100,000
2.8
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
65.31
Quantity 1,000 -1.2%
Value US$100,000
2.8
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
63.65
Quantity 1,000 -1.2%
Value US$100,000
2.8
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
62.59
Quantity 1,000 -18.6%
Value US$100,000
2.8
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Officer
Transaction date
Planned sale
Price
62.05
Quantity 1,000 -32.8%
Value US$100,000
2.7
Inrig Jula EVP, Head of R&D & CMO Officer
Transaction date
Planned sale
Price
65.31
Quantity 1,000 -0.4%
Value US$100,000
2.7
Inrig Jula EVP, Head of R&D & CMO Officer
Transaction date
Planned sale
Price
63.69
Quantity 1,000 -1.6%
Value US$100,000
2.7
Inrig Jula EVP, Head of R&D & CMO Officer
Transaction date
Planned sale
Price
62.62
Quantity 1,000 -14.4%
Value US$100,000
2.7
Inrig Jula EVP, Head of R&D & CMO Officer
Transaction date
Planned sale
Price
62.02
Quantity 1,000 -17.5%
Value US$100,000
2.5
REED ELIZABETH E Chief Legal Officer and GC Officer
Transaction date
Planned sale
Price
65.31
Quantity 1,000 -0.3%
Value US$100,000
2.5
REED ELIZABETH E Chief Legal Officer and GC Officer
Transaction date
Planned sale
Price
63.69
Quantity 1,000 -1.3%
Value US$100,000
2.5
REED ELIZABETH E Chief Legal Officer and GC Officer
Transaction date
Planned sale
Price
62.63
Quantity 1,000 -11.5%
Value US$100,000
2.5
REED ELIZABETH E Chief Legal Officer and GC Officer
Transaction date
Planned sale
Price
62.03
Quantity 1,000 -15.3%
Value US$100,000
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
65.31
Quantity 1,000 -0.1%
Value US$100,000
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
63.64
Quantity 1,000 -0.7%
Value US$100,000
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
62.66
Quantity 1,000 -6.2%
Value US$100,000
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
61.99
Quantity 1,000 -12.0%
Value US$100,000
2.7
Cline Christopher R. CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
65.31
Quantity 1,000 -0.5%
Value US$100,000
2.7
Cline Christopher R. CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
63.69
Quantity 1,000 -2.1%
Value US$100,000
2.7
Cline Christopher R. CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
62.61
Quantity 1,000 -18.8%
Value US$100,000
2.7
Cline Christopher R. CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
62.00
Quantity 1,000 -19.9%
Value US$100,000
2.9
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Officer
Transaction date
Planned sale
Price
63.66
Quantity 1,000 -0.7%
Value US$100,000
2.9
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Officer
Transaction date
Planned sale
Price
62.85
Quantity 1,000 -1.8%
Value US$100,000
2.9
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Officer
Transaction date
Planned sale
Price
62.14
Quantity 1,000 -9.0%
Value US$100,000
2.5
ELIZABETH REED Officer Officer
Transaction date
Proposed sale
Price
65.79
Quantity 1,000
Value US$100,000
2.9
SANDRA CALVIN Officer Officer
Transaction date
Proposed sale
Price
65.79
Quantity 1,000
Value US$100,000
2.7
CHRISTOPHER CLINE Officer Officer
Transaction date
Proposed sale
Price
65.79
Quantity 1,000
Value US$100,000
2.8
PETER HEERMA Officer Officer
Transaction date
Proposed sale
Price
65.79
Quantity 1,000
Value US$100,000
2.7
ERIC DUBE Director; Officer Executive Director
Transaction date
Proposed sale
Price
65.79
Quantity 1,000
Value US$100,000
2.3
WILLIAM ROTE Officer Officer
Transaction date
Proposed sale
Price
65.79
Quantity 1,000
Value US$100,000
2.7
JULA INRIG Officer Officer
Transaction date
Proposed sale
Price
65.79
Quantity 1,000
Value US$100,000
1.9
Meckler Jeffrey A Non-Executive Director
Transaction date
Planned sale
Price
68.09
Quantity 1,000 -3.3%
Value US$100,000
1.9
Meckler Jeffrey A Non-Executive Director
Transaction date
Planned sale
Price
67.46
Quantity 1,000 -12.9%
Value US$100,000
1.9
Meckler Jeffrey A Non-Executive Director
Transaction date
Planned sale
Price
66.15
Quantity 1,000 -1.1%
Value US$100,000
1.9
Meckler Jeffrey A Non-Executive Director
Transaction date
Planned sale
Price
65.39
Quantity 1,000 -1.5%
Value US$100,000
1.9
JEFFREY MECKLER Director Non-Executive Director
Transaction date
Proposed sale
Price
66.22
Quantity 1,000
Value US$100,000
2.7
Cline Christopher R. CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
66.37
Quantity 642 -0.5%
Value US$42,610
2.2
LYONS GARY A Non-Executive Director
Transaction date
Planned sale
Price
63.86
Quantity 900 -1.4%
Value US$57,470
2.2
LYONS GARY A Non-Executive Director
Transaction date
Planned sale
Price
63.27
Quantity 4,100 -6.2%
Value US$259,390
2.2
GARY LYONS Director Non-Executive Director
Transaction date
Proposed sale
Price
63.53
Quantity 5,000
Value US$317,650
2.2
LYONS GARY A Non-Executive Director
Transaction date
Planned sale
Price
64.16
Quantity 500 -0.8%
Value US$32,081
2.2
LYONS GARY A Non-Executive Director
Transaction date
Planned sale
Price
63.50
Quantity 2,600 -4.0%
Value US$165,100
2.2
LYONS GARY A Non-Executive Director
Transaction date
Planned sale
Price
62.53
Quantity 1,900 -2.9%
Value US$118,805
2.2
GARY A LYONS Director Non-Executive Director
Transaction date
Proposed sale
Price
62.14
Quantity 5,000
Value US$310,700
1.2
Coughlin Timothy Non-Executive Director
Transaction date
Planned sale
Price
50.07
Quantity 10,000 -15.1%
Value US$500,747
0.5
Baynes Roy D. Non-Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 4,500 -9.8%
Value US$225,000
0.5
ROY BAYNES Director Non-Executive Director
Transaction date
Proposed sale
Price
50.00
Quantity 4,500
Value US$225,000
1.2
Coughlin Timothy Director Non-Executive Director
Transaction date
Proposed sale
Price
50.04
Quantity 10,000
Value US$500,430
1.2
Coughlin Timothy Non-Executive Director
Transaction date
Planned sale
Price
43.49
Quantity 3,250 -5.9%
Value US$141,342
1.2
Coughlin Timothy Director Non-Executive Director
Transaction date
Proposed sale
Price
43.44
Quantity 3,250
Value US$141,183
2.7
Dube Eric M CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
43.95
Quantity 22,500 -4.9%
Value US$988,875
2.3
ROTE WILLIAM E. Chief Research Officer Officer
Transaction date
Planned sale
Price
43.95
Quantity 2,763 -2.3%
Value US$121,434
2.7
Inrig Jula CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
43.95
Quantity 311 -0.3%
Value US$13,668
2.7
Cline Christopher R. CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
43.95
Quantity 310 -0.3%
Value US$13,624
2.5
REED ELIZABETH E Chief Legal Officer and GC Officer
Transaction date
Planned sale
Price
43.95
Quantity 2,076 -1.9%
Value US$91,240
2.7
CHRISTOPHER CLINE Officer Officer
Transaction date
Proposed sale
Price
43.95
Quantity 310
Value US$13,624
2.7
JULA INRIG Officer Officer
Transaction date
Proposed sale
Price
43.95
Quantity 311
Value US$13,668
2.5
ELIZABETH REED Officer Officer
Transaction date
Proposed sale
Price
43.95
Quantity 2,076
Value US$91,240
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-17 2026-09-17 PlS Planned sale
2.8
Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

Officer
10,076 -5.9%
492.81
US$460,836 		10,076 -5.9% 492.81 US$460,836
2026-09-17 2026-09-17 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
89,645 -49.6%
450.14
US$4,016,008 		89,645 -49.6% 450.14 US$4,016,008
2026-09-17 2026-09-17 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
26,817 -5.7%
393.35
US$3,370,571 		26,817 -5.7% 393.35 US$3,370,571
2026-09-17 2026-09-17 PrS Proposed sale
2.7
ERIC DUBE

Director; Officer

Executive Director
1,000
63.48
US$100,000 		1,000 63.48 US$100,000
2026-09-17 2026-09-17 PrS Proposed sale
2.8
PETER HEERMA

Officer

Officer
1,000
63.48
US$100,000 		1,000 63.48 US$100,000
2026-09-17 2026-09-16 PlS Planned sale
2.3
ROTE WILLIAM E.

Chief Research Officer

Officer
1,000 -32.7%
63.61
US$100,000 		1,000 -32.7% 63.61 US$100,000
2026-09-17 2026-09-16 PlS Planned sale
2.3
ROTE WILLIAM E.

Chief Research Officer

Officer
1,000 -30.8%
63.12
US$100,000 		1,000 -30.8% 63.12 US$100,000
2026-09-17 2026-09-16 PlS Planned sale
2.8
Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

Officer
1,000 -40.3%
63.65
US$100,000 		1,000 -40.3% 63.65 US$100,000
2026-09-17 2026-09-16 PlS Planned sale
2.8
Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

Officer
1,000 -32.3%
63.25
US$100,000 		1,000 -32.3% 63.25 US$100,000
2026-09-17 2026-09-16 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
1,000 -18.2%
63.64
US$100,000 		1,000 -18.2% 63.64 US$100,000
2026-09-17 2026-09-16 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
1,000 -15.9%
63.26
US$100,000 		1,000 -15.9% 63.26 US$100,000
2026-09-16 2026-09-16 PrS Proposed sale
2.7
ERIC DUBE

Director; Officer

Executive Director
1,000
62.51
US$100,000 		1,000 62.51 US$100,000
2026-09-16 2026-09-16 PrS Proposed sale
2.3
WILLIAM ROTE

Officer

Officer
1,000
62.51
US$100,000 		1,000 62.51 US$100,000
2026-09-16 2026-09-16 PrS Proposed sale
2.8
PETER HEERMA

Officer

Officer
1,000
62.51
US$100,000 		1,000 62.51 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.3
ROTE WILLIAM E.

Chief Research Officer

Officer
1,000 -0.3%
65.31
US$100,000 		1,000 -0.3% 65.31 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.3
ROTE WILLIAM E.

Chief Research Officer

Officer
1,000 -3.0%
63.65
US$100,000 		1,000 -3.0% 63.65 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.3
ROTE WILLIAM E.

Chief Research Officer

Officer
1,000 -22.2%
62.66
US$100,000 		1,000 -22.2% 62.66 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.3
ROTE WILLIAM E.

Chief Research Officer

Officer
1,000 -32.9%
61.99
US$100,000 		1,000 -32.9% 61.99 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.8
Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

Officer
1,000 -1.2%
65.31
US$100,000 		1,000 -1.2% 65.31 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.8
Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

Officer
1,000 -1.2%
63.65
US$100,000 		1,000 -1.2% 63.65 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.8
Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

Officer
1,000 -18.6%
62.59
US$100,000 		1,000 -18.6% 62.59 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.8
Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

Officer
1,000 -32.8%
62.05
US$100,000 		1,000 -32.8% 62.05 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.7
Inrig Jula

EVP, Head of R&D & CMO

Officer
1,000 -0.4%
65.31
US$100,000 		1,000 -0.4% 65.31 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.7
Inrig Jula

EVP, Head of R&D & CMO

Officer
1,000 -1.6%
63.69
US$100,000 		1,000 -1.6% 63.69 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.7
Inrig Jula

EVP, Head of R&D & CMO

Officer
1,000 -14.4%
62.62
US$100,000 		1,000 -14.4% 62.62 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.7
Inrig Jula

EVP, Head of R&D & CMO

Officer
1,000 -17.5%
62.02
US$100,000 		1,000 -17.5% 62.02 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.5
REED ELIZABETH E

Chief Legal Officer and GC

Officer
1,000 -0.3%
65.31
US$100,000 		1,000 -0.3% 65.31 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.5
REED ELIZABETH E

Chief Legal Officer and GC

Officer
1,000 -1.3%
63.69
US$100,000 		1,000 -1.3% 63.69 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.5
REED ELIZABETH E

Chief Legal Officer and GC

Officer
1,000 -11.5%
62.63
US$100,000 		1,000 -11.5% 62.63 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.5
REED ELIZABETH E

Chief Legal Officer and GC

Officer
1,000 -15.3%
62.03
US$100,000 		1,000 -15.3% 62.03 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
1,000 -0.1%
65.31
US$100,000 		1,000 -0.1% 65.31 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
1,000 -0.7%
63.64
US$100,000 		1,000 -0.7% 63.64 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
1,000 -6.2%
62.66
US$100,000 		1,000 -6.2% 62.66 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
1,000 -12.0%
61.99
US$100,000 		1,000 -12.0% 61.99 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.7
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
1,000 -0.5%
65.31
US$100,000 		1,000 -0.5% 65.31 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.7
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
1,000 -2.1%
63.69
US$100,000 		1,000 -2.1% 63.69 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.7
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
1,000 -18.8%
62.61
US$100,000 		1,000 -18.8% 62.61 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.7
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
1,000 -19.9%
62.00
US$100,000 		1,000 -19.9% 62.00 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.9
Calvin Sandra

SVP, CHIEF ACCOUNTING OFFICER

Officer
1,000 -0.7%
63.66
US$100,000 		1,000 -0.7% 63.66 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.9
Calvin Sandra

SVP, CHIEF ACCOUNTING OFFICER

Officer
1,000 -1.8%
62.85
US$100,000 		1,000 -1.8% 62.85 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
2.9
Calvin Sandra

SVP, CHIEF ACCOUNTING OFFICER

Officer
1,000 -9.0%
62.14
US$100,000 		1,000 -9.0% 62.14 US$100,000
2026-09-15 2026-09-15 PrS Proposed sale
2.5
ELIZABETH REED

Officer

Officer
1,000
65.79
US$100,000 		1,000 65.79 US$100,000
2026-09-15 2026-09-15 PrS Proposed sale
2.9
SANDRA CALVIN

Officer

Officer
1,000
65.79
US$100,000 		1,000 65.79 US$100,000
2026-09-15 2026-09-15 PrS Proposed sale
2.7
CHRISTOPHER CLINE

Officer

Officer
1,000
65.79
US$100,000 		1,000 65.79 US$100,000
2026-09-15 2026-09-15 PrS Proposed sale
2.8
PETER HEERMA

Officer

Officer
1,000
65.79
US$100,000 		1,000 65.79 US$100,000
2026-09-15 2026-09-15 PrS Proposed sale
2.7
ERIC DUBE

Director; Officer

Executive Director
1,000
65.79
US$100,000 		1,000 65.79 US$100,000
2026-09-15 2026-09-15 PrS Proposed sale
2.3
WILLIAM ROTE

Officer

Officer
1,000
65.79
US$100,000 		1,000 65.79 US$100,000
2026-09-15 2026-09-15 PrS Proposed sale
2.7
JULA INRIG

Officer

Officer
1,000
65.79
US$100,000 		1,000 65.79 US$100,000
2026-09-11 2026-09-10 PlS Planned sale
1.9
Meckler Jeffrey A
Non-Executive Director
1,000 -3.3%
68.09
US$100,000 		1,000 -3.3% 68.09 US$100,000
2026-09-11 2026-09-10 PlS Planned sale
1.9
Meckler Jeffrey A
Non-Executive Director
1,000 -12.9%
67.46
US$100,000 		1,000 -12.9% 67.46 US$100,000
2026-09-11 2026-09-10 PlS Planned sale
1.9
Meckler Jeffrey A
Non-Executive Director
1,000 -1.1%
66.15
US$100,000 		1,000 -1.1% 66.15 US$100,000
2026-09-11 2026-09-10 PlS Planned sale
1.9
Meckler Jeffrey A
Non-Executive Director
1,000 -1.5%
65.39
US$100,000 		1,000 -1.5% 65.39 US$100,000
2026-09-10 2026-09-10 PrS Proposed sale
1.9
JEFFREY MECKLER

Director

Non-Executive Director
1,000
66.22
US$100,000 		1,000 66.22 US$100,000
2026-09-03 2026-09-02 S Sale
2.7
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
642 -0.5%
66.37
US$42,610 		642 -0.5% 66.37 US$42,610
2026-08-19 2026-08-18 PlS Planned sale
2.2
LYONS GARY A
Non-Executive Director
900 -1.4%
63.86
US$57,470 		900 -1.4% 63.86 US$57,470
2026-08-19 2026-08-18 PlS Planned sale
2.2
LYONS GARY A
Non-Executive Director
4,100 -6.2%
63.27
US$259,390 		4,100 -6.2% 63.27 US$259,390
2026-08-18 2026-08-18 PrS Proposed sale
2.2
GARY LYONS

Director

Non-Executive Director
5,000
63.53
US$317,650 		5,000 63.53 US$317,650
2026-08-19 2026-08-17 PlS Planned sale
2.2
LYONS GARY A
Non-Executive Director
500 -0.8%
64.16
US$32,081 		500 -0.8% 64.16 US$32,081
2026-08-19 2026-08-17 PlS Planned sale
2.2
LYONS GARY A
Non-Executive Director
2,600 -4.0%
63.50
US$165,100 		2,600 -4.0% 63.50 US$165,100
2026-08-19 2026-08-17 PlS Planned sale
2.2
LYONS GARY A
Non-Executive Director
1,900 -2.9%
62.53
US$118,805 		1,900 -2.9% 62.53 US$118,805
2026-08-17 2026-08-17 PrS Proposed sale
2.2
GARY A LYONS

Director

Non-Executive Director
5,000
62.14
US$310,700 		5,000 62.14 US$310,700
2026-06-16 2026-06-12 PlS Planned sale
1.2
Coughlin Timothy
Non-Executive Director
10,000 -15.1%
50.07
US$500,747 		10,000 -15.1% 50.07 US$500,747
2026-06-16 2026-06-12 PlS Planned sale
0.5
Baynes Roy D.
Non-Executive Director
4,500 -9.8%
50.00
US$225,000 		4,500 -9.8% 50.00 US$225,000
2026-06-12 2026-06-12 PrS Proposed sale
0.5
ROY BAYNES

Director

Non-Executive Director
4,500
50.00
US$225,000 		4,500 50.00 US$225,000
2026-06-12 2026-06-12 PrS Proposed sale
1.2
Coughlin Timothy

Director

Non-Executive Director
10,000
50.04
US$500,430 		10,000 50.04 US$500,430
2026-05-19 2026-05-15 PlS Planned sale
1.2
Coughlin Timothy
Non-Executive Director
3,250 -5.9%
43.49
US$141,342 		3,250 -5.9% 43.49 US$141,342
2026-05-15 2026-05-15 PrS Proposed sale
1.2
Coughlin Timothy

Director

Non-Executive Director
3,250
43.44
US$141,183 		3,250 43.44 US$141,183
2026-05-06 2026-05-06 PlS Planned sale
2.7
Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
22,500 -4.9%
43.95
US$988,875 		22,500 -4.9% 43.95 US$988,875
2026-05-06 2026-05-06 PlS Planned sale
2.3
ROTE WILLIAM E.

Chief Research Officer

Officer
2,763 -2.3%
43.95
US$121,434 		2,763 -2.3% 43.95 US$121,434
2026-05-06 2026-05-06 PlS Planned sale
2.7
Inrig Jula

CHIEF MEDICAL OFFICER

Officer
311 -0.3%
43.95
US$13,668 		311 -0.3% 43.95 US$13,668
2026-05-06 2026-05-06 PlS Planned sale
2.7
Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
310 -0.3%
43.95
US$13,624 		310 -0.3% 43.95 US$13,624
2026-05-06 2026-05-06 PlS Planned sale
2.5
REED ELIZABETH E

Chief Legal Officer and GC

Officer
2,076 -1.9%
43.95
US$91,240 		2,076 -1.9% 43.95 US$91,240
2026-05-06 2026-05-06 PrS Proposed sale
2.7
CHRISTOPHER CLINE

Officer

Officer
310
43.95
US$13,624 		310 43.95 US$13,624
2026-05-06 2026-05-06 PrS Proposed sale
2.7
JULA INRIG

Officer

Officer
311
43.95
US$13,668 		311 43.95 US$13,668
2026-05-06 2026-05-06 PrS Proposed sale
2.5
ELIZABETH REED

Officer

Officer
2,076
43.95
US$91,240 		2,076 43.95 US$91,240
Explore more

More insider trading research around Travere Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America